FI83389C - Baerarsystem foer samtidig frigoering av tvao eller flera aktiva aemnen. - Google Patents
Baerarsystem foer samtidig frigoering av tvao eller flera aktiva aemnen. Download PDFInfo
- Publication number
- FI83389C FI83389C FI853952A FI853952A FI83389C FI 83389 C FI83389 C FI 83389C FI 853952 A FI853952 A FI 853952A FI 853952 A FI853952 A FI 853952A FI 83389 C FI83389 C FI 83389C
- Authority
- FI
- Finland
- Prior art keywords
- release
- active substance
- container
- containers
- active
- Prior art date
Links
- 239000013543 active substance Substances 0.000 claims description 53
- 238000009792 diffusion process Methods 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 description 12
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 10
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 10
- 229960002568 ethinylestradiol Drugs 0.000 description 10
- 229920000260 silastic Polymers 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- 239000000262 estrogen Substances 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- -1 polysiloxane Polymers 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- GCKFUYQCUCGESZ-BPIQYHPVSA-N etonogestrel Chemical compound O=C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 GCKFUYQCUCGESZ-BPIQYHPVSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 229930182833 estradiol Natural products 0.000 description 5
- 229960005309 estradiol Drugs 0.000 description 5
- 239000000328 estrogen antagonist Substances 0.000 description 5
- 229940044953 vaginal ring Drugs 0.000 description 5
- 239000006213 vaginal ring Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 230000001076 estrogenic effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000000583 progesterone congener Substances 0.000 description 4
- 239000004408 titanium dioxide Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003433 contraceptive agent Substances 0.000 description 2
- 230000002254 contraceptive effect Effects 0.000 description 2
- 229960004400 levonorgestrel Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229920001515 polyalkylene glycol Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-SFFUCWETSA-N 17α-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-SFFUCWETSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229910001316 Ag alloy Inorganic materials 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- YNVGQYHLRCDXFQ-XGXHKTLJSA-N Lynestrenol Chemical compound C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 YNVGQYHLRCDXFQ-XGXHKTLJSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000001833 anti-estrogenic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229960004976 desogestrel Drugs 0.000 description 1
- RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 229940106582 estrogenic substances Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- JKKFKPJIXZFSSB-CBZIJGRNSA-N estrone 3-sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-N 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960001910 lynestrenol Drugs 0.000 description 1
- 229960004296 megestrol acetate Drugs 0.000 description 1
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940053934 norethindrone Drugs 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 229960002831 norgestrienone Drugs 0.000 description 1
- GVDMJXQHPUYPHP-FYQPLNBISA-N norgestrienone Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)C#C)C=C3)C3=C21 GVDMJXQHPUYPHP-FYQPLNBISA-N 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8403120 | 1984-10-12 | ||
| NL8403120 | 1984-10-12 | ||
| NL8403626 | 1984-11-29 | ||
| NL8403626 | 1984-11-29 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI853952A0 FI853952A0 (fi) | 1985-10-10 |
| FI853952L FI853952L (fi) | 1986-04-13 |
| FI83389B FI83389B (fi) | 1991-03-28 |
| FI83389C true FI83389C (fi) | 1991-07-10 |
Family
ID=26645989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI853952A FI83389C (fi) | 1984-10-12 | 1985-10-10 | Baerarsystem foer samtidig frigoering av tvao eller flera aktiva aemnen. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4596576A (show.php) |
| EP (1) | EP0180264A1 (show.php) |
| KR (1) | KR930003315B1 (show.php) |
| CN (1) | CN1005607B (show.php) |
| AU (1) | AU578117B2 (show.php) |
| CA (1) | CA1254142A (show.php) |
| DK (1) | DK454985A (show.php) |
| ES (1) | ES296113Y (show.php) |
| FI (1) | FI83389C (show.php) |
| GR (1) | GR852464B (show.php) |
| IL (1) | IL76651A (show.php) |
| NO (1) | NO171706C (show.php) |
| NZ (1) | NZ213796A (show.php) |
| PT (1) | PT81295B (show.php) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4961931A (en) * | 1982-07-29 | 1990-10-09 | Alza Corporation | Method for the management of hyperplasia |
| US5188835A (en) * | 1986-06-16 | 1993-02-23 | Kabi Pharmacia Ab | Intravaginal devices |
| SE8602666D0 (sv) * | 1986-06-16 | 1986-06-16 | Leo Ab | Intravaginal devices |
| EP0303306B1 (en) * | 1987-08-08 | 1993-03-10 | Akzo N.V. | Contraceptive implant |
| NZ228382A (en) * | 1989-03-17 | 1992-08-26 | Carter Holt Harvey Plastic Pro | Drug administering coil-like device for insertion in body cavity of animal |
| FI95768C (fi) | 1993-06-17 | 1996-03-25 | Leiras Oy | Emättimensisäinen antosysteemi |
| US5443461A (en) * | 1993-08-31 | 1995-08-22 | Alza Corporation | Segmented device for simultaneous delivery of multiple beneficial agents |
| DE69616551T2 (de) * | 1995-07-04 | 2002-05-29 | Akzo Nobel N.V., Arnheim/Arnhem | Ringförmige vorrichtung |
| US6030375A (en) * | 1996-03-29 | 2000-02-29 | Iotek, Inc. | Compressible vaginal insert and method for treating urogenital disorders |
| US5816248A (en) * | 1996-03-29 | 1998-10-06 | Iotek, Inc. | Channeled vaginal insert and method for treating urogenital disorders |
| US5988169A (en) * | 1996-03-29 | 1999-11-23 | Iotek, Inc. | Vaginal insert and method for treating urogenital disorders |
| US5972372A (en) * | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
| US6183461B1 (en) | 1998-03-11 | 2001-02-06 | Situs Corporation | Method for delivering a medication |
| AU748653B2 (en) * | 1998-05-01 | 2002-06-06 | John F. Cline | Method for injection molding manufacture of controlled release devices |
| US6361780B1 (en) * | 1998-11-12 | 2002-03-26 | Cardiac Pacemakers, Inc. | Microporous drug delivery system |
| CN1289064C (zh) * | 2001-08-31 | 2006-12-13 | 先灵有限责任公司 | 药物输送体系 |
| US7187980B2 (en) * | 2001-11-09 | 2007-03-06 | Oscor Inc. | Cardiac lead with steroid eluting ring |
| GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
| US7357046B2 (en) * | 2002-12-16 | 2008-04-15 | N. V. Organon | Method for dissolution testing of a pharmaceutical delivery device |
| WO2004096151A2 (en) * | 2003-04-29 | 2004-11-11 | The General Hospital Corporation | Methods and devices for the sustained release of multiple drugs |
| TWI336627B (en) | 2003-05-23 | 2011-02-01 | Organon Nv | Drug delivery system,and use and manufacturing method thereof |
| US8481079B2 (en) * | 2004-03-24 | 2013-07-09 | Merck Sharp & Dohme B.V. | Drug delivery system based on polyethylene vinylacetate copolymers |
| GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
| US20080095822A1 (en) * | 2004-11-16 | 2008-04-24 | Universite De Liege | Active Substance Delivery System Comprising A Hydrogel Atrix And Microcarriers |
| EP1853221A2 (en) * | 2005-02-03 | 2007-11-14 | Duramed Pharmaceuticals, Inc. | Devices for delivering agents to a vaginal tract |
| TW200727920A (en) * | 2005-06-21 | 2007-08-01 | Organon Nv | New regimens for oral monophasic contraceptives |
| TW200744610A (en) * | 2005-06-21 | 2007-12-16 | Organon Nv | New regimens for controlled drug delivery devices for contraception |
| ES2359513T3 (es) | 2005-07-19 | 2011-05-24 | The Population Council, Inc. | Métodos y composiciones para anticoncepción de emergencia usando antagonistas del receptor de endotelina. |
| US8088161B2 (en) * | 2005-07-28 | 2012-01-03 | Visioncare Ophthalmic Technologies Inc. | Compressed haptics |
| GB0613333D0 (en) * | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
| GB0613638D0 (en) * | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
| BRPI0713203A2 (pt) * | 2006-07-12 | 2012-04-03 | Controlled Therapeutics Scotland Ltda | inserto, métodos, embalagem, dispositivo recuperável e dispositivo inserìvel |
| GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
| TW200930343A (en) * | 2007-09-21 | 2009-07-16 | Organon Nv | Drug delivery system |
| TW200927141A (en) * | 2007-11-22 | 2009-07-01 | Bayer Schering Pharma Oy | Vaginal delivery system |
| AU2009313304B2 (en) * | 2008-11-07 | 2014-07-24 | Vimac Ventures, Llc | Devices and methods for treating and/or preventing diseases |
| FI121000B (fi) * | 2008-11-19 | 2010-06-15 | Bayer Schering Pharma Oy | Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi |
| US8753667B2 (en) | 2009-07-21 | 2014-06-17 | The Population Council, Inc. | Multi-layered gradient vaginal ring |
| US8580294B2 (en) | 2010-10-19 | 2013-11-12 | International Partnership For Microbicides | Platinum-catalyzed intravaginal rings |
| WO2012138542A1 (en) | 2011-04-07 | 2012-10-11 | Arstat, Inc. | Treatment of menstrual pain and excessive menstrual blood loss by intravaginal administration of a low dose of antifibrinolytic or hemostatic agent in combination with non- steroidal anti-inflammatory drug |
| WO2013029194A1 (es) | 2011-08-26 | 2013-03-07 | Universidad De Santiago De Chile | Uso de los anti-inflamatorios no esteroidales meloxicam y piroxicam, por via intravaginal, para la interrupción del proceso ovulatorio en la mujer |
| TWI615155B (zh) * | 2011-11-01 | 2018-02-21 | 拜耳股份有限公司 | 滲透活性的陰道遞送系統 |
| EP2641602A1 (en) | 2012-03-23 | 2013-09-25 | PregLem S.A. | Method for treating gynecological diseases |
| TR201808748T4 (tr) | 2012-09-03 | 2018-07-23 | Ecosea Farming S A | Hidrobiyolojik türlerin kültürü ve/veya korunmasına yönelik rezervuar-kafes daldırma sistemi. |
| EP2964088B1 (en) | 2013-03-08 | 2023-05-10 | Li Galli B.V. i.o. | Vaginal drug delivery and/or diagnostic system |
| UY35528A (es) | 2013-04-10 | 2014-09-30 | Preglem Sa | Moduladores del receptor de la progesterona para uso en la terapia de fibromas uterinos |
| FR3005417B1 (fr) * | 2013-05-10 | 2015-05-22 | Blaise Francois Figuereo | Anneau vaginal tri-reservoir, a retro-largage compatible avec les caracteristiques des molecules actives qu'il contient |
| SE539540C2 (sv) | 2013-09-12 | 2017-10-10 | Qpharma Ab | Ett läkemedelsavgivningssystem för en eller flera aktiva beståndsdelar |
| US10137031B2 (en) | 2013-11-14 | 2018-11-27 | International Partnership For Microbicides, Inc. | Combination therapy intravaginal rings |
| EP3079659B1 (en) | 2013-12-11 | 2020-10-28 | Merck Sharp & Dohme B.V. | Drug delivery system for delivery of anti-virals |
| US10413504B2 (en) | 2013-12-11 | 2019-09-17 | Merck Sharp & Dohme Corp. | Intravaginal ring drug delivery system |
| KR102159904B1 (ko) | 2020-04-24 | 2020-09-24 | 강경원 | 약물 방출 고리를 구비한 월경컵 |
| EP4507675A1 (en) * | 2022-04-14 | 2025-02-19 | Yale University | Nanoparticles and nanoparticle-releasing vaginal rings |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3911911A (en) * | 1969-06-16 | 1975-10-14 | Reese Hospital Michael | Anti-fertility device |
| US3995633A (en) | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal Medicament dispensing device |
| US3995634A (en) | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal cavity dispensing means and method |
| US4286587A (en) * | 1978-10-11 | 1981-09-01 | Alza Corporation | Vaginal drug delivery system made from polymer |
| US4237885A (en) * | 1978-10-23 | 1980-12-09 | Alza Corporation | Delivery system with mated members for storing and releasing a plurality of beneficial agents |
| US4304232A (en) * | 1979-03-14 | 1981-12-08 | Alza Corporation | Unit system having multiplicity of means for dispensing useful agent |
| US4250611A (en) * | 1979-04-19 | 1981-02-17 | Alza Corporation | Process for making drug delivery device with reservoir |
| US4326522A (en) * | 1980-06-09 | 1982-04-27 | Pitman-Moore, Inc. | Mesh-covered bolus |
| GB2079158B (en) * | 1980-06-09 | 1985-01-09 | Ahi Operations Ltd | Intra-vaginal devices |
| US4526578A (en) * | 1983-05-16 | 1985-07-02 | Alza Corporation | Vaginal diaphragm |
-
1985
- 1985-10-01 EP EP85201580A patent/EP0180264A1/en not_active Ceased
- 1985-10-01 US US06/782,433 patent/US4596576A/en not_active Expired - Fee Related
- 1985-10-04 DK DK454985A patent/DK454985A/da not_active Application Discontinuation
- 1985-10-10 IL IL76651A patent/IL76651A/xx not_active IP Right Cessation
- 1985-10-10 FI FI853952A patent/FI83389C/fi not_active IP Right Cessation
- 1985-10-10 GR GR852464A patent/GR852464B/el unknown
- 1985-10-11 KR KR1019850007483A patent/KR930003315B1/ko not_active Expired - Fee Related
- 1985-10-11 NO NO854047A patent/NO171706C/no unknown
- 1985-10-11 NZ NZ213796A patent/NZ213796A/xx unknown
- 1985-10-11 ES ES1985296113U patent/ES296113Y/es not_active Expired
- 1985-10-11 CN CN85107921.0A patent/CN1005607B/zh not_active Expired
- 1985-10-11 AU AU48512/85A patent/AU578117B2/en not_active Ceased
- 1985-10-11 CA CA000492837A patent/CA1254142A/en not_active Expired
- 1985-10-11 PT PT81295A patent/PT81295B/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO171706C (no) | 1993-04-28 |
| NZ213796A (en) | 1989-04-26 |
| PT81295B (pt) | 1987-10-20 |
| AU578117B2 (en) | 1988-10-13 |
| FI83389B (fi) | 1991-03-28 |
| KR860003028A (ko) | 1986-05-19 |
| DK454985D0 (da) | 1985-10-04 |
| IL76651A0 (en) | 1986-02-28 |
| NO171706B (no) | 1993-01-18 |
| CA1254142A (en) | 1989-05-16 |
| CN85107921A (zh) | 1986-06-10 |
| DK454985A (da) | 1986-04-13 |
| ES296113Y (es) | 1988-05-16 |
| PT81295A (en) | 1985-11-01 |
| AU4851285A (en) | 1986-04-17 |
| ES296113U (es) | 1987-12-16 |
| FI853952L (fi) | 1986-04-13 |
| US4596576A (en) | 1986-06-24 |
| GR852464B (show.php) | 1986-02-11 |
| FI853952A0 (fi) | 1985-10-10 |
| EP0180264A1 (en) | 1986-05-07 |
| KR930003315B1 (ko) | 1993-04-26 |
| NO854047L (no) | 1986-04-14 |
| IL76651A (en) | 1990-06-10 |
| CN1005607B (zh) | 1989-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI83389C (fi) | Baerarsystem foer samtidig frigoering av tvao eller flera aktiva aemnen. | |
| RU2206325C2 (ru) | Система доставки лекарственных препаратов для двух или более активных веществ | |
| US4350271A (en) | Water absorbing fluid dispenser | |
| US5254346A (en) | Occlusive body for administering a physiologically active substance | |
| DE3634864C2 (de) | Abgabevorrichtung zum Freisetzen einer wärmeempfindlichen Wirkstoffzubereitung | |
| CA1078734A (en) | Controlled release article | |
| US4663148A (en) | Dispenser comprising telescopically engaging members | |
| US4663149A (en) | Dispenser comprising inner and outer walls functioning as cooperative unit | |
| JPS584574B2 (ja) | 固体のゼロオ−ダ−放出装置 | |
| US3924622A (en) | Zero-order release method | |
| US4814180A (en) | Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container | |
| NL8602022A (nl) | Afgiftesysteem met een voorziening voor het onmiddellijk afgeven van een middel. | |
| US4716031A (en) | Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug | |
| US4800056A (en) | Process for making dispenser with cooperating elements | |
| JPH0137367B2 (show.php) | ||
| US4031202A (en) | Controlled release contraceptive article | |
| AU679847B2 (en) | Sustained release preparations | |
| JPS61106508A (ja) | ２種以上の活性物質の放出システム | |
| US4145408A (en) | Controlled release article | |
| MXPA98002799A (en) | System of delivery of medication for two or massubstancias acti | |
| CA1335256C (en) | Occlusive body for administering a physiologically active substance | |
| HK1016886B (en) | Drug delivery system for two or more active substances |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: AKZO N.V. |